Related Experiment Video
Updated: Jun 23, 2026

Use of Image Cytometry for Quantification of Pathogenic Fungi in Association with Host Cells
Published on: June 19, 2013
Quantifying the hidden impact of COVID-19 pandemic: The cytology perspective
Elham Yousefi1, Edmund S Cibas1, Jeffrey K Mito1
1Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.
Insights
The COVID-19 pandemic significantly reduced cytology specimen collection, impacting timely diagnoses. This decline in gynecologic and non-gynecologic samples led to fewer identified malignant cases, highlighting delayed care.
Area of Science:
- Medical diagnostics
- Pathology
- Public health
Background:
- The COVID-19 pandemic's impact extends beyond mortality, affecting healthcare resources and patient mobility.
- Non-COVID related diseases faced an increased burden due to pandemic-related disruptions.
Purpose of the Study:
- To evaluate the impact of the COVID-19 pandemic on diagnostic cytology.
- To analyze trends in cytology specimen volume and diagnoses during the pandemic.
Main Methods:
- Time series analysis of cytology specimens from January 2019 to April 2021.
- Utilized moving averages, time trend analysis, and cross-correlation.
Main Results:
- A sharp decrease in gynecologic (-89.4%) and non-gynecologic (-70.4%) cytology specimens occurred during the first pandemic peak.
- A correlation was observed between sample numbers and COVID-19 cases in early 2020.
- A smaller decline in specimens was noted during the second surge, but 154 fewer malignant cases were identified in the initial months.
Conclusions:
- COVID-19 pandemic's effects include significant reductions in diagnostic cytology specimen volume.
- This decrease has serious implications, potentially leading to delayed patient care and missed diagnoses.
- The decline in specimen numbers and subsequent missed diagnoses were not fully recovered within the study period.
Background:
The burden of the COVID-19 pandemic is often enumerated in lives lost, but the strain on health care resources and mobility limitations contributed to the burden of non-COVID related disease. In this study, we evaluated the impact of the pandemic through a time series review of cytology samples.
Methods:
Pathology reports for all cytology specimens received from January 2019 through April 2021 at our institution were reviewed. Time series analysis was performed using moving averages, time trend analysis, cross-correlation, and tests of homogeneity.
Results:
During the first peak of the pandemic (March-June 2020), breakpoint analysis showed a downward shift in the number of gynecologic (-89.4%) and non-gynecologic (-70.4%) cytology specimens within a week of declaration of an emergency. Cross-correlation analysis showed a relationship between sample numbers and COVID-19 cases during the initial phase of the pandemic (April-June 2020). During the second surge (October 2020-April 2021), despite the higher incidence of COVID-19, there was a smaller impact on cytology samples (-20.1% and - 24.8% for gynecologic and non-gynecologic samples, respectively). During the first 3 months of the pandemic, 154 fewer malignant cases were identified compared with the prior year. Although specimen numbers slowly returned to baseline following the first wave of the pandemic, the earlier decline in malignant diagnoses was not offset during the study period.
Conclusions:
The deleterious effects of COVID-19 extend beyond direct mortality attributed to the disease. The significant decrease in diagnostic cytology specimens during this period has profound implications including delayed care and missed disease.
More Related Videos
Related Concept Videos
Causality in Epidemiology
Steps in Outbreak Investigation
Infectious Diseases and Their Occurrence
Cytomegalovirus Disease
Coronavirus

